MADISON, Wis., and SAN DIEGO -- FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, and PhenoVista Biosciences (PhenoVista), a top provider of custom imaging-based phenotypic assay services, today announce a strategic alliance to improve the drug discovery process, by using iPSCs in screening. This alliance [...]

MENLO PARK, Calif. -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands will increase their SMRT sequencing capacity with the addition of two new PacBio Sequel IIe Systems. Radboudumc has been using PacBio long-read technology for the last three years [...]

BOSTON --  908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, today announced that GlaxoSmithKline (NYSE: GSK) has purchased an additional REBEL™ cell culture media analyzer. GSK will now have a total of five REBEL analyzers being used by its biologics and vaccine process development teams. “We are pleased that GSK [...]

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Aldous Wong as President of the Asia Pacific region. Reporting to Group Chief Executive Andrew Williams, Aldous will lead Halma’s growth in China and the wider region. This will include seeking new M&A opportunities and growing Halma’s existing companies in [...]

Expanding range of applications for growing base of QIAcuity digital PCR instruments Two new collaborations: Atila BioSystems expands menu to non-invasive prenatal testing (NIPT), while Actome partnership designed to enable for the first time protein analysis using digital PCR technology HILDEN, Germany & GERMANTOWN, Md. -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today [...]

PHILADELPHIA -- Boekel Scientific, a globally recognized designer and manufacturer of laboratory equipment and medical devices, including market-leading blood banking products, is proud to be among the companies displaying the new Corporate Partner logo of AABB (The Association for the Advancement of Blood and Biotherapies). AABB is a connected community dedicated to advancing transfusion medicine and biotherapies. Its [...]

CHELMSFORD, Mass. -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th. In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. "We are excited to have Matt join the Company as our [...]

LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the addition of Elaine R. Mardis, Ph.D., to the Company’s Board of Directors. Dr. Mardis is a pioneering researcher internationally recognized in cancer genomics with a focus on [...]

Univercells S.A. (Univercells) today announced its acquisition of SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through an unprecedented robust, scalable and automated DNA synthesis technology resulting in one-step generation of long DNA fragments, at large quantities, high purity in a cGMP-compliant setup. SynHelix’s offering will complement the RNA platform being developed by [...]

Merck has signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO), for approximately USD 780 million in cash. Targeted acquisition to accelerate novel modalities service offering Exelead, a full-service CDMO, focusing on Lipid Nanoparticle formulations enhances Merck’s mRNA and lipid manufacturing capabilities Customers will benefit from unique and integrated [...]